Variant report
Variant | nsv466166 |
---|---|
Chromosome Location | chr9:10546779-10592492 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375371380 | chr9:10548431-10548432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577337376 | chr9:10548442-10548443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138062824 | chr9:10548448-10548449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558191449 | chr9:10548493-10548494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552174587 | chr9:10548522-10548523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191072286 | chr9:10548533-10548534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543805458 | chr9:10548535-10548536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554173957 | chr9:10548548-10548549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574661658 | chr9:10548565-10548566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540122709 | chr9:10548571-10548572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148869591 | chr9:10548616-10548617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369692757 | chr9:10548618-10548619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560420220 | chr9:10548621-10548622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182414474 | chr9:10548684-10548685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546018358 | chr9:10548728-10548729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568163452 | chr9:10548747-10548748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199500596 | chr9:10548748-10548749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs33948585 | chr9:10548749-10548750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112186177 | chr9:10548778-10548779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs185561330 | chr9:10548786-10548787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548586927 | chr9:10548797-10548798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557108406 | chr9:10555417-10555418 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573991166 | chr9:10555452-10555453 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536515904 | chr9:10555455-10555456 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553631401 | chr9:10555469-10555470 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs833412 | chr9:10555471-10555472 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs189765882 | chr9:10555477-10555478 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182992341 | chr9:10555511-10555512 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577841496 | chr9:10555533-10555534 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544791606 | chr9:10555547-10555548 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543390283 | chr9:10555552-10555553 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs833413 | chr9:10555561-10555562 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs60234108 | chr9:10556838-10556839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112080913 | chr9:10556847-10556848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12380636 | chr9:10556850-10556851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552866558 | chr9:10556861-10556862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538706211 | chr9:10556869-10556870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376209797 | chr9:10556888-10556889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369390524 | chr9:10556896-10556897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555440370 | chr9:10556897-10556898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184846963 | chr9:10556909-10556910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188961025 | chr9:10556931-10556932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138650874 | chr9:10556933-10556934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371799652 | chr9:10556944-10556945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181693244 | chr9:10556950-10556951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552651172 | chr9:10556961-10556962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186392434 | chr9:10556984-10556985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558402042 | chr9:10557006-10557007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574884525 | chr9:10557030-10557031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543849998 | chr9:10557049-10557050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10548400-10548800 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr9:10548400-10548800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr9:10548400-10548800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr9:10555400-10555600 | Bivalent Enhancer | Esophagus | oesophagus |
5 | chr9:10556800-10557600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr9:10556800-10557600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr9:10557200-10557600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr9:10557200-10557600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:10557400-10557800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr9:10557600-10558000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr9:10561400-10564200 | Enhancers | NHEK | skin |
12 | chr9:10561600-10562200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr9:10562000-10562800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr9:10562200-10562600 | Enhancers | HMEC | breast |
15 | chr9:10562200-10563800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr9:10562600-10563000 | Weak transcription | HMEC | breast |
17 | chr9:10562800-10563200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr9:10563000-10564200 | Enhancers | HMEC | breast |
19 | chr9:10563200-10563600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr9:10563800-10564200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
21 | chr9:10571800-10572000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr9:10571800-10572000 | Enhancers | Spleen | Spleen |
23 | chr9:10586200-10587200 | Enhancers | NHEK | skin |